Ds. Smith et al., Mycobacterium terrae: Case reports, literature review, and in vitro antibiotic susceptibility testing, CLIN INF D, 30(3), 2000, pp. 444-453
Mycobacterium terrae infection can cause debilitating disease that is relat
ively resistant to antibiotic therapy. Two cases are presented, and data fr
om an additional 52 reports from the literature are reviewed. Tenosynovitis
of the upper extremity, often following trauma, was the most commonly repo
rted presentation (59% of cases), with pulmonary disease occurring in an ad
ditional 26% of cases, Underlying medical problems were absent (44%) or not
reported (28%) in 72% of the cases. One-half of the patients with upper ex
tremity tenosynovitis were treated with local or systemic corticosteroids,
before microbiological identification. Only one-half of the patients with t
enosynovitis who were followed up for 6 months had clinical improvement or
were cured. The other one-half of the patients required repeated debridemen
t, tendon extirpation, or amputation. The best antimicrobial therapy for M.
terrae infection is unknown but might include a macrolide antibiotic plus
ethambutol and one other effective drug for at least 12 months after clinic
al response. Parenteral treatment with an aminoglycoside and surgery may be
useful in selected cases.